Individuals who are interested in seeking the following may benefit from microdosing GLP-1/GIP + B12: Metabolic Health Individuals with insulin resistance or prediabetes may benefit from Tirzepatides ability to stabilize blood sugar and improve insulin sensitivity
Since its launch by Novo Nordisk in early 2026, oral semaglutide has been the first oral GLP-1 approved specifically for weight loss
That result was groundbreaking at the time
2 The FDAs official statement builds on Commissioner Marty Makarys X post from February 5 th , saying that the agency would move against copycat drugs marketed as comparable to approved therapies, warning that regulators will take swift action against companies mass-marketing illegal copycat drugs, claiming they are similar to FDA-approved products
However, safe does not mean without consideration. Medical Monitoring is Essential Any time you combine medications that affect the central nervous system or metabolic function, you must be under the care of a licensed healthcare provider
Nausea, diarrhea, constipation, and decreased appetite are most common